Web of Science:
The impact of intraoperative Fogarty balloon dilation on arteriovenous fistula success: clinical and functional outcomes

dc.contributor.authorErsoy, G.G.
dc.contributor.authorTamtekin, B.
dc.contributor.authorTaskent, I.
dc.date.accessioned2025-02-15T18:51:25Z
dc.date.available2025-02-15T18:51:25Z
dc.date.issued2024.01.01
dc.description.abstractBackground: An effectively functioning arteriovenous fistula (AVF) is vital for end-stage renal disease patients. This study aims to evaluate the effects of Fogarty (R) balloon catheter dilation on creating an effectively functioning AVF. Methods: This retrospective cohort study was conducted at our clinic between 2020 and 2022. A total of 120 patients underwent arteriovenous fistula (AVF) creation with intraoperative Fogarty (R) balloon catheter dilation. Inclusion criteria required the presence of a palpable radial artery and superficial vein in the non-dominant arm, which was confirmed via Doppler ultrasound when necessary. The surgical approach involved side-to-side anastomosis between the radial artery and cephalic vein, followed by intraoperative dilation of the artery, vein, and anastomotic area using a Fogarty (R) balloon catheter after completion of the anastomosis. Results: The study included 120 patients aged between 26 and 89 years, with a nearly equal gender distribution (57 females, 47.5%; and 63 males, 52.5%). The success rate of arteriovenous fistulas (AVFs) was evaluated according to the number of patients who were able to start adequate hemodialysis 6 weeks after surgery. At 6-week follow-up, 114 patients successfully started hemodialysis through these AVFs. In contrast, six patients could not obtain an adequate AVF for effective hemodialysis. As a result, the overall success rate was calculated as 95%. Conclusions: This study suggests that intraoperative Fogarty balloon dilatation may contribute positively to the success rate of AVF creation. The findings indicate that this technique could be considered as a potential intraoperative strategy to optimize AVF outcomes, especially in patients with challenging vascular anatomy or a history of AVF failure.
dc.identifier.doi10.23736/S0392-9590.24.05351-3
dc.identifier.eissn1827-1839
dc.identifier.endpage635
dc.identifier.issn0392-9590
dc.identifier.issue6
dc.identifier.startpage629
dc.identifier.urihttps://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=dspace_ku&SrcAuth=WosAPI&KeyUT=WOS:001412642500008&DestLinkType=FullRecord&DestApp=WOS_CPL
dc.identifier.urihttps://hdl.handle.net/20.500.12597/34095
dc.identifier.volume43
dc.identifier.wos001412642500008
dc.language.isoen
dc.relation.ispartofINTERNATIONAL ANGIOLOGY
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectHemodialysis
dc.subjectVascular patency
dc.subjectCatheters
dc.titleThe impact of intraoperative Fogarty balloon dilation on arteriovenous fistula success: clinical and functional outcomes
dc.typeArticle
dspace.entity.typeWos
local.indexed.atWOS

Files